BIODESIX INC (BDSX) Stock Cash Flow
NASDAQ:BDSX - Nasdaq - US09075X1081 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.42M | -42.93M | -52.15M | -65.45M | -43.16M | |||
| Depreciation Amortization | 5.79M | 5.77M | 3.33M | 3.60M | 3.18M | |||
| Change In Working Capital | 4.37M | 1.59M | 13.96M | -3.44M | 4.59M | |||
| Interest Paid | 6.93M | 7.02M | 3.99M | 1.01M | 1.68M | |||
| Other non cash items | -11.68M | -13.09M | 11.98M | 20.32M | 7.17M | |||
| OPERATING CASH FLOW | -41.94M | -48.65M | -22.87M | -44.97M | -28.22M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.30M | -3.44M | -23.06M | -3.53M | -2.55M | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -3.30M | -3.44M | -23.06M | -3.53M | -2.55M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -45.00K | -51.00K | 9.95M | 16.50M | -15.35M | |||
| Stock Issued/Repurchased | N/A | 55.65M | 28.22M | 59.81M | 17.11M | |||
| Other Financing Activity | -3.62M | -3.55M | -9.04M | -17.42M | -500.00K | |||
| FINANCING CASH FLOW | 51.36M | 52.05M | 29.13M | 58.88M | 1.26M | |||
| CHANGE IN CASH | 6.11M | -39.00K | -16.80M | 10.38M | -29.51M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -41.94M | -48.65M | -22.87M | -44.97M | -28.22M | |||
| Capital Expenditure | -3.30M | -3.44M | -23.06M | -3.53M | -2.55M | |||
| FREE CASH FLOW | -45.24M | -52.09M | -45.93M | -48.50M | -30.77M | |||
All data in USD